Page last updated: 2024-10-24

smooth muscle tissue development

Definition

Target type: biologicalprocess

The process whose specific outcome is the progression of smooth muscle over time, from its formation to the mature structure. [GOC:dph, GOC:jid, GOC:lm]

Smooth muscle tissue development is a complex and tightly regulated process that involves a series of coordinated events, from the commitment of progenitor cells to the formation of functional muscle fibers. This process is essential for the proper development of a wide range of organs and tissues, including the cardiovascular system, digestive system, respiratory system, and reproductive system.

**1. Commitment of Progenitor Cells:**
The process begins with the commitment of multipotent mesenchymal progenitor cells to a smooth muscle lineage. This commitment is regulated by a complex network of signaling pathways, including the Wnt, TGF-β, and BMP pathways. These pathways activate specific transcription factors, such as SRF (serum response factor) and myocardin, which drive the expression of smooth muscle-specific genes.

**2. Proliferation and Differentiation:**
Once committed, smooth muscle progenitor cells undergo a period of rapid proliferation to expand the pool of smooth muscle cells. Concurrently, they begin to differentiate, acquiring the characteristic features of smooth muscle cells, including contractile proteins, such as actin and myosin, and specific smooth muscle-associated proteins, such as calponin and SM22α.

**3. Assembly of Contractile Machinery:**
The newly synthesized contractile proteins assemble into organized sarcomeres, the basic contractile units of smooth muscle. These sarcomeres are attached to dense bodies, which are specialized structures that anchor the contractile proteins to the cell membrane and the cytoskeleton.

**4. Formation of Smooth Muscle Fibers:**
Individual smooth muscle cells then align and connect with each other, forming long, interconnected fibers. This process is facilitated by cell-cell adhesion molecules, such as cadherins and integrins. The fibers are organized into layers, with different layers often having distinct functions, such as contraction and relaxation.

**5. Vascularization and Innervation:**
As the smooth muscle tissue develops, it becomes vascularized, receiving a blood supply that provides oxygen and nutrients. It also becomes innervated, receiving signals from the nervous system that regulate its contractile activity.

**6. Maturation and Functional Integration:**
The smooth muscle tissue continues to mature and refine its function throughout development and even into adulthood. This includes the fine-tuning of contractile properties, the establishment of specific connections with other tissues, and the integration into functional organ systems.

The development of smooth muscle tissue is a complex process that involves a precise interplay of genetic and environmental factors. Dysregulation of this process can lead to a variety of developmental abnormalities and diseases, highlighting the importance of understanding this intricate process.'
"

Proteins (3)

ProteinDefinitionTaxonomy
Smoothened homologA protein smoothened that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q99835]Homo sapiens (human)
Sonic hedgehog proteinA sonic hedgehog protein that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q15465]Homo sapiens (human)
Bone morphogenetic protein 4A bone morphogenetic protein 4 that is encoded in the genome of human. [PRO:CNA, UniProtKB:P12644]Homo sapiens (human)

Compounds (20)

CompoundDefinitionClassesRoles
jervinejervine: teratogen from Veratrum grandiflorum; RN given refers to parent cpd(3beta,23beta)-isomer; structurepiperidines
cyclopaminepiperidinesglioma-associated oncogene inhibitor
pd 173955PD 173955: inhibits src family-selective tyrosine kinase; structure in first sourcearyl sulfide;
dichlorobenzene;
methyl sulfide;
pyridopyrimidine
tyrosine kinase inhibitor
purmorphaminepurmorphamine : A member of the class of purines that is purine substituted at C-2 by a 1-naphthyloxy group, at C-4 by a 4-morpholinophenylamino group, and at N-9 by a cyclohexyl group.

purmorphamine: structure in first source
aromatic ether;
morpholines;
purines;
secondary amino compound
osteogenesis regulator;
SMO receptor agonist
cur 61414CUR 61414: inhibits the hedehog signaling pathway; structure in first source
abt 869aromatic amine;
indazoles;
phenylureas
angiogenesis inhibitor;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
dorsomorphindorsomorphin : A pyrazolopyrimidine that is pyrazolo[1,5-a]pyrimidine which is substituted at positions 3 and 6 by pyridin-4-yl and p-[2-(piperidin-1-yl)ethoxy]phenyl groups, respectively. It is a potent, selective, reversible, and ATP-competitive inhibitor of AMPK (AMP-activated protein kinase, EC 2.7.11.31) and a selective inhibitor of bone morphogenetic protein (BMP) signaling.

dorsomorphin: an AMPK inhibitor
aromatic ether;
piperidines;
pyrazolopyrimidine;
pyridines
bone morphogenetic protein receptor antagonist;
EC 2.7.11.31 {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase} inhibitor
lde225sonidegib : A member of the classo of biphenyls that is the amide obtained by formal condensation of the carboxy group of 2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxylic acid with the amino group of 6-(2,6-dimethylmorpholin-4-yl)pyridin-3-amine. Used (as its phosphate salt) for treatment of locally advanced basal cell carcinoma.

sonidegib: specific Smoothened/Smo antagonist
aminopyridine;
aromatic ether;
benzamides;
biphenyls;
morpholines;
organofluorine compound;
tertiary amino compound
antineoplastic agent;
Hedgehog signaling pathway inhibitor;
SMO receptor antagonist
gdc 0449HhAntag691: inhibits the hedgehog pathway and ABC transporters; has antineoplastic activitybenzamides;
monochlorobenzenes;
pyridines;
sulfone
antineoplastic agent;
Hedgehog signaling pathway inhibitor;
SMO receptor antagonist;
teratogenic agent
N-[[3-fluoro-4-[[2-(1-methyl-4-imidazolyl)-7-thieno[3,2-b]pyridinyl]oxy]anilino]-sulfanylidenemethyl]-2-phenylacetamidethioureas
ipi-926IPI-926: a semisynthetic derivative of cyclopamine that is a smoothened inhibitor with antineoplastic activity; structure in first sourcepiperidines
robotnikininrobotnikinin: binds sonic hedgehog protein to block its signaling pathway; structure in first source
ldn 193189LDN 193189: inhibits bone morphogenetic protein signalingpyrimidines
gsk 1363089GSK 1363089: a multikinase inhibitor that acts on Met, RON, Axl, and VEGFR; structure in first sourcearomatic ether
tak-441TAK-441: structure in first source
ml347ML347: an ALK2 inhibitor; structure in first source
ly2940680
3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylureaBGJ-398 : A member of the class of phenylureas that is urea in which a hydrogen attached to one of the nitrogens is replaced by a 2,6-dichloro-3,5-dimethoxyphenyl group, while the hydrogens attached to the other nitrogen are replaced by a methyl group and a 6-{[4-(4-ethylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl group. It is a potent and selective fibroblast growth factor receptor inhibitor.

infigratinib: structure in first source
aminopyrimidine;
dichlorobenzene;
N-alkylpiperazine;
N-arylpiperazine;
phenylureas
antineoplastic agent;
fibroblast growth factor receptor antagonist
cep-32496agerafenib: inhibitor of RAF family kinases; structure in first source
pf-52748571-(4-(5'-chloro-3,5-dimethyl-2,4'-bipyridin-2'-yl)piperazin-1-yl)-3-(methylsulfonyl)propan-1-one: a potent and selective Smoothened antagonist that penetrates the blood-brain barrier; structure in first source